| Literature DB >> 35978309 |
Naoko Matsuda1, Seung Chik Jwa2, Saki Tamura1, Hiroyuki Suzuki1, Masashi Takamura1, Akira Namba1, Takeshi Kajihara1, Ryugo Okagaki1, Yoshimasa Kamei1, Osamu Ishihara1.
Abstract
BACKGROUND: This study aimed to determine the factors associated with an unfavorable clinical course (emergency surgery and/or prolonged hospitalization) in patients requiring hospitalization owing to pelvic inflammatory disease (PID).Entities:
Keywords: Body mass index; C-reactive protein; Endometriosis; Pelvic inflammatory disease; Risk factors; Tubo-ovarian abscess
Mesh:
Year: 2022 PMID: 35978309 PMCID: PMC9387057 DOI: 10.1186/s12905-022-01925-5
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.742
Baseline characteristics of sample population (n = 117)
| Mean ± SD or n (%) | |
|---|---|
| Age (years) | 41.2 ± 12.5 |
| Parity | |
| 0 | 58 (49.6) |
| ≥ 1 | 59 (50.4) |
| BMI (Kg/m2) | 23.7 ± 5.0 |
| < 18.5 | 11 (9.4) |
| 18.5–25 | 69 (59.0) |
| 25–30 | 22 (18.8) |
| ≥ 30 | 15 (12.8) |
| Smoking | 15 (12.8) |
| Post-menopause | 16 (13.7) |
| Past medical history of PID | 21 (18.0) |
| DM | 3 (2.6) |
| Gynecological conditions | |
| Uterine fibroma | 37 (31.6) |
| Endometriosis | 63 (53.9) |
| Adenomyosis | 19 (16.2) |
| Intrauterine manipulation | 19 (16.2) |
| Endometrial biopsy | 9 (7.7) |
| Removal of IUD | 2 (1.7) |
| Embryo transfer | 6 (5.1) |
| Hysterosalpingography | 2 (1.7) |
| Positive for PCR testing for Chlamydia trachomatisa | 4 (5.1) |
| Sexual intercourse before the onset of PID | 9 (7.7) |
| Fever (≧38.0 °C) at admission | 43 (36.8) |
| Tubo-ovarian abscess | 81 (69.2) |
| Bilateral | 20 (24.7) |
| Size of abscess, (cm) | 5.8 (1.5) |
| WBC at admission, (× 103/μL) | 14.6 ± 5.2 |
| CRP at admission, (mg/dL) | 12.0 ± 9.6 |
a78 patients were tested for DNA-PCR of Chlamydia trachomatis
BMI body mass index, CRP C-reactive protein, DM diabetes mellitus, IUD intrauterine device, PID pelvic inflammatory disease, SD standard deviation, WBC white blood cell count
Surgical intervention and duration of hospitalization stratified by tubo-ovarian abscess
| Without TOA (n = 36) | With TOA (n = 81) | ||
|---|---|---|---|
| Emergency surgery | 3 (8.3) | 21 (25.9) | 0.03 |
| Hospital length of stay, (days) | |||
| Emergency surgery (n = 24) | 8.0 ± 2.0 | 17.1 ± 5.6 | 0.01 |
| Successful expectant management (n = 93) | 8.3 ± 5.3 | 9.4 ± 4.6 | 0.31 |
Data are shown as mean ± SD or n (%)
TOA, tubo-ovarian abscess
Crude and adjusted odd ratios of risk factors for emergency surgery (n = 117)
| Crude OR (95% CI) | Adjusted OR | |||
|---|---|---|---|---|
| Age (years) | 1.03 (0.998 to 1.07) | 0.07 | – | – |
| Parity | ||||
| 0 | Reference | – | – | |
| ≥ 1 | 2.33 (0.91 to 5.96) | 0.08 | – | – |
| BMI | ||||
| < 18.5 | 0.96 (0.18 to 4.97) | 0.96 | – | – |
| 18.5–25 | Reference | – | – | |
| 25–30 | 2.01 (0.68 to 5.93) | 0.21 | – | – |
| > 30 | 0.66 (0.13 to 3.30) | 0.62 | – | – |
| Smoking | 2.18 (0.67 to 7.13) | 0.20 | ||
| Post-menopause | 2.77 (0.89 to 8.59) | 0.08 | ||
| Past medical history of PID | 2.32 (0.81 to 6.62) | 0.12 | ||
| DM | 1.98 (0.17 to 22.8) | 0.58 | – | – |
| Uterine fibroma | 0.86 (0.32 to 2.31) | 0.77 | – | – |
| Endometrioma | 0.82(0.34 to 2.02) | 0.67 | – | – |
| Adenomyosis | 1.04 (0.31 to 3.48) | 0.95 | – | – |
| Intrauterine manipulation | 2.05 (0.69 to 6.13) | 0.20 | 3.27 (0.90 to 11.8) | 0.07 |
| Sexual intercourse before the onset of PID | 0.46 (0.05 to 3.88) | 0.48 | – | – |
| Fever (≧38.0 °C) | 0.65 (0.25 to 1.73) | 0.39 | – | – |
| Tubo-ovarian abscess | 3.58 (0.90 to 14.2) | 0.07 | ||
| WBC at admission | 0.994 (0.91 to 1.09) | 0.90 | – | – |
| CRP at admission | ||||
BMI body mass index, CI confidence interval, CRP C-reactive protein, DM diabetes mellitus, OR odds ratio, PID pelvic inflammatory disease, WBC white blood cell count
Significantly increased or reduced odds are indicated by boldface
Coefficient of risk factors for duration of hospitalization among patients with successful expectant management (n = 93)
| Coefficient (95% CI) | Adjusted coefficient | |||
|---|---|---|---|---|
| Age (years) | ||||
| Parity | ||||
| 0 | Reference | – | – | |
| ≥ 1 | 0.10 (− 1.90 to 2.11) | 0.92 | – | – |
| BMI | ||||
| < 18.5 | − 0.93 (− 4.28 to 2.41) | 0.58 | 0.40 (− 2.55 to 3.35) | 0.79 |
| 18.5–25 | Reference | Reference | ||
| 25–30 | 1.73 (− 0.98 to 4.44) | 0.21 | 0.88 (− 1.58 to 3.35) | 0.48 |
| > 30 | ||||
| Smoking | − 1.31 (− 4.52 to 1.91) | 0.42 | – | – |
| Post-menopause | 0.71 (− 2.51 to 3.93) | 0.66 | ||
| Past medical history of PID | 0.54 (− 2.25 to 3.33) | 0.70 | – | |
| DM | 3.61 (− 3.24 to 10.5) | 0.31 | – | – |
| Uterine fibroma | 1.97 (− 0.13 to 4.06) | 0.07 | – | – |
| Endometrioma | 1.07 (− 0.93 to 3.07) | 0.29 | – | – |
| Adenomyosis | – | – | ||
| Intrauterine manipulation | 0.48 (− 2.39 to 3.36) | 0.74 | – | – |
| Sexual intercourse before the onset of PID | − 2.56 (− 6.09 to 0.96) | 0.15 | – | – |
| Fever (≧38.0 °C) | 1.64 (− 0.38 to 3.66) | 0.11 | – | – |
| Tubo-ovarian abscess | 1.08 (− 1.0 to 3.15) | 0.31 | – | – |
| WBC at admission | ||||
| CRP at admission | ||||
BMI body mass index, CI confidence interval, CRP C-reactive protein, DM diabetes mellitus, OR odds ratio, PID pelvic inflammatory disease, WBC white blood cell count
Significantly increased or reduced coefficients are indicated by boldface